These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10574266)

  • 1. Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.
    Ito Y; Matsuura N; Sakon M; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Monden M
    Br J Cancer; 1999 Oct; 81(4):747-51. PubMed ID: 10574266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Bcl-xL in human hepatocellular carcinoma.
    Watanabe J; Kushihata F; Honda K; Sugita A; Tateishi N; Mominoki K; Matsuda S; Kobayashi N
    Surgery; 2004 Jun; 135(6):604-12. PubMed ID: 15179366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
    Tannapfel A; Geissler F; Köckerling F; Katalinic A; Hauss J; Wittekind C
    J Pathol; 1999 Mar; 187(4):439-45. PubMed ID: 10398104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage of elevated ets-2 expression to hepatocarcinogenesis.
    Ito Y; Miyoshi E; Takeda T; Nagano H; Sakon M; Noda K; Tsujimoto M; Monden M; Matsuura N
    Anticancer Res; 2002; 22(4):2385-9. PubMed ID: 12174931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and possible role of ets-1 in hepatocellular carcinoma.
    Ito Y; Miyoshi E; Takeda T; Sakon M; Noda K; Tsujimoto M; Monden M; Taniguchi N; Matsuura N
    Am J Clin Pathol; 2000 Nov; 114(5):719-25. PubMed ID: 11068545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
    Mitsuhashi N; Kobayashi S; Doki T; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Miura S; Miyazaki M
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e189-97. PubMed ID: 18466288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.
    Wu PC; Fang JW; Lau VK; Lai CL; Lo CK; Lau JY
    Am J Pathol; 1996 Oct; 149(4):1167-75. PubMed ID: 8863666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
    Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C
    Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.
    Fukuda S; Itamoto T; Nakahara H; Kohashi T; Ohdan H; Hino H; Ochi M; Tashiro H; Asahara T
    Hepatogastroenterology; 2005; 52(64):1163-7. PubMed ID: 16001653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis.
    Lee RG; Tsamandas AC; Demetris AJ
    Hepatology; 1997 Dec; 26(6):1415-22. PubMed ID: 9397980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth index, assessed with Ki-67 and ssDNA labeling; a significant prognosticator for patients undergoing curative resection for hepatocellular carcinoma.
    Morinaga S; Ishiwa N; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    J Surg Oncol; 2005 Dec; 92(4):331-6. PubMed ID: 16299800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S; Saji S; Kuno T
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of death-associated protein-kinase expression in hepatocellular carcinomas.
    Matsumoto H; Nagao M; Ogawa S; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Fujii H; Koyama F; Mukogawa T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1333-41. PubMed ID: 12820391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.
    Ito Y; Monden M; Takeda T; Eguchi H; Umeshita K; Nagano H; Nakamori S; Dono K; Sakon M; Nakamura M; Tsujimoto M; Nakahara M; Nakao K; Yokosaki Y; Matsuura N
    Br J Cancer; 2000 Mar; 82(6):1211-7. PubMed ID: 10735508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients.
    Koike Y; Nakagawa K; Shiratori Y; Shiina S; Imamura M; Sato S; Obi S; Teratani T; Hamamura K; Yoshida H; Omata M
    Hepatogastroenterology; 2003; 50(54):2035-9. PubMed ID: 14696460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
    Zhuang PY; Zhang JB; Zhu XD; Zhang W; Wu WZ; Tan YS; Hou J; Tang ZY; Qin LX; Sun HC
    Cancer; 2008 Jun; 112(12):2740-8. PubMed ID: 18412155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    World J Surg; 2002 Sep; 26(9):1133-8. PubMed ID: 12209243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.